Manufacturing / Pharmaceutical Preparations
Actinium Pharmaceuticals, Inc.
ATNM
$1.09
+$0.02 (+1.85%)
Price as of Oct 9, 2026 21:38 UTC
33 M
Market Cap (Micro Cap)
Nov 12
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $1.15
- Above 50-day average $1.10
- Above 200-day average $1.17 · -8.4%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) 30d ago
Volume
- Below-average volume 0.7x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for ATNM options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Sep 02, 2026 | Nicholson, C. David | Grant | 94,200 | $0 | +8.0% | |
| Sep 02, 2026 | Shetty Ajit | Grant | 61,600 | $0 | +8.0% | |
| Sep 02, 2026 | Almenoff June Sherie | Grant | 18,000 | $0 | +8.0% | |
| Sep 02, 2026 | SETH SANDESH | Grant | 753,600 | $0 | +8.0% | |
| Sep 02, 2026 | Steinhart Richard I | Grant | 94,200 | $0 | +8.0% | |
| Sep 02, 2026 | Nicholson, C. David | Grant | 62,800 | $0 | +8.0% | |
| Sep 02, 2026 | Shetty Ajit | Grant | 92,400 | $0 | +8.0% | |
| Sep 02, 2026 | SETH SANDESH | Grant | 1,027,274 | $0 | +8.0% | |
| Sep 02, 2026 | Chell Jeffrey W. | Grant | 92,400 | $0 | +8.0% | |
| Sep 02, 2026 | Chell Jeffrey W. | Grant | 61,600 | $0 | +8.0% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 06, 2026 | Q2 2026 | -$0.22 | |||
| Mar 31, 2026 | Q1 2026 | -$0.24 | -$0.18 | +24.9% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.19 | -$0.20 | -5.0% | Miss |
| Sep 30, 2025 | Q3 2025 | -$0.33 | -$0.16 | +51.5% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.36 | -$0.22 | +38.4% | Beat |
| Mar 31, 2025 | Q4 2025 | -$0.19 | -$0.20 | -5.0% | Miss |
Track ATNM with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ATNM and your entire portfolio.